The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy

Authors: Passero, Frank C., Grapsa, Dimitra, Syrigos, Kostas N., Saif, Muhammad Wasif

Source: Expert review of anticancer therapy. 16(7):697-703

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100106679221.0x000001&indx=1&recIds=ETOCvdc_100106679221.0x000001

Nutrition Habits, Physical Activity, and Lung Cancer: An Authoritative Review

Authors: Koutsokera, Alexandra, Kiagia, Maria, Saif, Muhammad W., Souliotis, Kyriakos, Syrigos, Kostas N.

Source: In Clinical Lung Cancer July 2013 14(4):342-350

The Role of Endobronchial Ultrasound in Lung Cancer Diagnosis and Staging: A Comprehensive Review

Authors: Kokkonouzis, Ioannis, Strimpakos, Alexios S., Lampaditis, Ioannis, Tsimpoukis, Sotirios, Syrigos, Kostas N.

Source: In Clinical Lung Cancer November 2012 13(6):408-415

Chemotherapy-induced neutropenia in lung cancer patients: The role of antibiotic prophylaxis

Authors: Kouranos, Vasileios, Dimopoulos, George, Vassias, Antonios, Syrigos, Kostas N.

Source: In Cancer Letters 2011 313(1):9-14

Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients

Authors: Charpidou, Andriani, Gkiozos, Ioannis, Konstantinou, Marios, Eleftheraki, Anastasia, Demertzis, Panagiotis, Harrington, Kevin, Polyzos, Aris, Syrigos, Kostas N.

Source: In Cancer Letters 2011 304(2):144-153

Targeted therapeutic approaches for hormone-refractory prostate cancer

Authors: Stavridi, Flora, Karapanagiotou, Eleni M., Syrigos, Kostas N.

Source: In Cancer Treatment Reviews 2010 36(2):122-130

Hypersensitivity Reactions to Oxaliplatin: A Retrospective Study and the Development of a Desensitization Protocol

Authors: Syrigou, Ekaterini I., Karapanagiotou, Eleni M., Alamara, Christina V., Boura, Paraskevi G., Saif, Muhammad W., Syrigos, Kostas N.

Source: In Clinical Colorectal Cancer 2009 8(2):106-109

Erlotinib-Induced Skin Rash in Patients with Non–Small-Cell Lung Cancer: Pathogenesis, Clinical Significance, and Management

Authors: Tsimboukis, Sotirios, Merikas, Irene, Karapanagiotou, Eleni M., Saif, Muhammad Wasif, Syrigos, Kostas N.

Source: In Clinical Lung Cancer 2009 10(2):106-111

Head and neck cancer in the elderly: An overview on the treatment modalities

Authors: Syrigos, Kostas N., Karachalios, Dimitris, Karapanagiotou, Eleni M., Nutting, Christopher M., Manolopoulos, Leonidas, Harrington, Kevin J.

Source: In Cancer Treatment Reviews 2009 35(3):237-245

The role of mTOR in the management of solid tumors: An overview

Authors: Strimpakos, Alex S., Karapanagiotou, Eleni M., Saif, M. Wasif, Syrigos, Kostas N.

Source: In Cancer Treatment Reviews 2009 35(2):148-159

Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients

Authors: Karapanagiotou, Eleni M., Polyzos, Aristidis, Dilana, Kalliopi D., Gratsias, Ioannis, Boura, Paraskevi, Gkiozos, Ioannis, Syrigos, Kostas N.

Source: In Lung Cancer 2009 66(3):393-398

Predictive and prognostic significance of PIOS (Patras Immunotherapy Score) model in patients with advanced NSCLC treated with nivolumab or pembrolizumab: Results from a validation cohort.

Authors: Dimtrakopoulos, Foteinos-Ioannis D., Mountzios, Giannis Socrates, Christopoulos, Petros, Papastergiou, Thomas, Zervas, Eleftherios, Agelaki, Sofia, Samantas, Epaminondas, Athanasiadis, Ilias, Baka, Sofia, Syrigos, Kostas N., Christopoulou, Athina, Lianos, Evangelos, Tsoukalas, Nikolaos, Perdikouri, Eleni Isidora, Oikonomopoulos, Georgios, Kalofonou, Foteini, Makatsoris, Thomas, Koutras, Angelos, Megalooikonomou, Vasileios, Kalofonos, Haralabos

Source: Journal of clinical oncology. 39(15 suppl):e21164-e21164

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173222367.0x000001&indx=1&recIds=ETOCvdc_100173222367.0x000001

Prolonged survival after splenectomy in Wiskott-Aldrich syndrome: a case report

Authors: Tsimpoukis Sotirios, Moutsos Michael, Neidhart Jeffrey, Makrilia Nektaria, Syrigos Kostas N, Kiagia Maria, Saif Muhammad W

Source: Italian Journal of Pediatrics, Vol 37, Iss 1, p 42 (2011)

Subject Terms: Wiskott-Aldrich syndrome, thrombocytopenia, splenectomy, survival, treatment, Pediatrics, RJ1-570

File Description: electronic resource

Relation: http://www.ijponline.net/content/37/1/42; https://doaj.org/toc/1720-8424; https://doaj.org/toc/1824-7288

Access URL: https://doaj.org/article/d63d421f2af244fdaa54c757c1c22203

Bevacizumab-Induced Hypertension.

Authors: Syrigos, Kostas N.¹, Karapanagiotou, Eleni², Boura, Paraskevi¹ viviboura@gmail.com, Manegold, Christian³, Harrin, Kevin⁴

Source: BioDrugs. 2011, Vol. 25 Issue 3, p159-169. 11p.

Subject Terms: *BEVACIZUMAB, *DRUG side effects, *HYPERTENSION, *MONOCLONAL antibodies, *VASCULAR endothelial growth factors, *COLON cancer treatment, *SMALL cell lung cancer, *CANCER treatment, *RENAL cell carcinoma

Geographic Terms: UNITED States, EUROPE

Company/Entity: UNITED States. Food & Drug Administration

Role of Vitamin D in the Prevention of Pancreatic Cancer.

Authors: Bulathsinghala, Pubudu¹, Syrigos, Kostas N.² knsyrigos@usa.net, Saif, Muhammad W.³

Source: Journal of Nutrition & Metabolism. 2010, p1-9. 9p.

Subject Terms: *VITAMIN D, *PANCREATIC cancer, *CANCER, *THERAPEUTICS, *PREVENTIVE medicine, *ANTI-inflammatory agents, *SUN, *NUTRITION, *MEDICAL research

Sunitinib.

Authors: Papaetis, Georgios S.¹ gpapaetis@yahoo.gr, Syrigos, Kostas N.¹

Source: BioDrugs. 2009, Vol. 23 Issue 7, p377-389. 13p. 1 Diagram, 2 Charts.

Subject Terms: *PROTEIN-tyrosine kinases, *PROTEIN kinases, *VASCULAR endothelial growth factors, *PLATELET-derived growth factor, *RENAL cell carcinoma

Sunitinib: A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies.

Authors: Papaetis, Georgios S.¹, Syrigos, Kostas N.¹

Source: BioDrugs. 2009, Vol. 23 Issue 6, p377-389. 13p. 1 Diagram, 2 Charts.

Subject Terms: *CARDIOVASCULAR agents, *PROTEIN-tyrosine kinases, *VASCULAR endothelial growth factors, *DRUG side effects, *RENAL cell carcinoma, *GASTROINTESTINAL stromal tumors

Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma.

Authors: Mohammad, Mustafa M.¹, Syrigos, Kostas N.², Saif, M. Wasif^1,3 wsaif@tuftsmedicalcenter.org

Source: Case Reports in Dermatological Medicine. 2013, p1-3. 3p.

Subject Terms: *PERITONEAL cancer, *DRUG efficacy, *VINORELBINE, *PRIMARY care, *CETUXIMAB, *CANCER treatment

Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib

Authors: Vergou, Theognosia, Stratigos, Alexander J., Karapanagiotou, Eleni M., Matekovits, Athina E., Dilana, Kalliopi D., Tsimboukis, Sotirios, Antoniou, Christina, Chasapi, Vassiliki, Syrigos, Kostas N.

Source: In Journal of the American Academy of Dermatology 2010 63(2):e56-e58

This result is not displayed to guests.
Login for full access.